Chromatin remodelling is required for gene reactivation after DNA demethylation as induced by DAC treatment [47] and the combination of DNMT and histone deacetylase (HDAC) inhibitors has been shown to induce re-expression of tumour suppressor genes in ovarian and colon cancer cell cultures [48,49]. Here, DNMT1 is linked to malignant colon neoplasm.